Koers Optigenex Inc. Other OTC
Aandelen
OPGX
US6838863032
Farmaceutische producten
Omzet 2006 | 301K 277K | Omzet 2007 | 466K 430K | Marktkapitalisatie | 44,73K 41,25K |
---|---|---|---|---|---|
Nettowinst (verlies) 2006 | -7 mln. -6,45 mln. | Nettowinst (verlies) 2007 | -2 mln. -1,84 mln. | EV/omzet 2006 | 20,5 x |
Nettoschuld 2006 | 6 mln. 5,53 mln. | Nettoschuld 2007 | 8,93 mln. 8,24 mln. | EV/omzet 2007 | 19,3 x |
K/w-verhouding 2006 * |
-
| K/w-verhouding 2007 |
-
| Werknemers | - |
Dividendrendement 2006 * |
-
| Dividendrendement 2007 |
-
| Vrij verhandelbaar | 21,27% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Daniel A. Zwiren
CEO | Chief Executive Officer | 67 | 13-05-06 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Daniel A. Zwiren
CEO | Chief Executive Officer | 67 | 13-05-06 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,73% | 739 mld. | |
+32,83% | 598 mld. | |
-6,30% | 353 mld. | |
+15,15% | 318 mld. | |
+4,05% | 285 mld. | |
+15,00% | 240 mld. | |
+9,78% | 210 mld. | |
-5,52% | 206 mld. | |
+6,17% | 164 mld. |